Discovery of ILT3 (LILRB4) Small Molecule Inhibitors by Affinity Se-lection-Mass Spectrometry Reveals Druggability of a Neuroimmune Checkpoint in Alzheimers Disease
Somaya A. Abdel‐Rahman, N. Arul Murugan, Moustafa Tarek Gabr
This study identifies small molecule inhibitors of ILT3 using AS-MS, showing they improve cognition and reduce amyloid in Alzheimer's disease models.
European Journal of Medicinal Chemistry Reports · Oct 1, 2026Peer-reviewedPharmacology & Toxicology